Exane Derivatives Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$7.46M |
| 2 |
Linde
LIN
|
+$6.13M |
| 3 |
Logitech
LOGI
|
+$3.75M |
| 4 |
Coca-Cola
KO
|
+$1.49M |
| 5 |
Amazon
AMZN
|
+$990K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stellantis
STLA
|
+$14.3M |
| 2 |
iShares S&P 500 Value ETF
IVE
|
+$7.54M |
| 3 |
Alcon
ALC
|
+$5.41M |
| 4 |
Ferrari
RACE
|
+$5.16M |
| 5 |
CNH
CNH Industrial
CNH
|
+$2.87M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.48% |
| 2 | Technology | 15.28% |
| 3 | Consumer Discretionary | 11.12% |
| 4 | Healthcare | 10.96% |
| 5 | Industrials | 9.78% |
Similar funds
Exane Derivatives's Q3 2021 Portfolio in Review
As of Q3 2021, Exane Derivatives held 1,096 positions worth $417M, down 5.6% from $441M the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Exane Derivatives withdrew a net $15.1M in Q3 2021, closing 50 positions and reducing 328 holdings. Its most notable exit was Kraft Heinz, an estimated $1.62M position sold in full.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 13% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Exane Derivatives opened a new position in Discovery, Inc. Series C Common Stock worth $796K.
- Exane Derivatives's largest Q3 2021 buy was Discovery, Inc. Series C Common Stock: 32,809 shares worth $796K.
- Exane Derivatives added most to UBS Group in Q3 2021, an estimated $7.46M increase.
- Exane Derivatives's biggest Q3 2021 reduction was Stellantis, cutting an estimated $14.3M.
- Exane Derivatives fully exited Kraft Heinz in Q3 2021, selling an estimated $1.62M.
- Exane Derivatives's ten largest holdings make up 23% of its $417M portfolio in Q3 2021.
- Exane Derivatives opened 51 new positions and closed 50 in Q3 2021.
- Exane Derivatives's portfolio value fell 5.6% quarter-over-quarter to $417M.
Based on Exane Derivatives's 13F filing for Q3 2021, filed 26 Oct 2021.